Literature DB >> 22967807

Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging.

Yongming Wang1, Wendy Y Zhang, Shijun Hu, Feng Lan, Andrew S Lee, Bruno Huber, Leszek Lisowski, Ping Liang, Mei Huang, Patricia E de Almeida, Jong H Won, Ning Sun, Robert C Robbins, Mark A Kay, Fyodor D Urnov, Joseph C Wu.   

Abstract

RATIONALE: Molecular imaging has proven to be a vital tool in the characterization of stem cell behavior in vivo. However, the integration of reporter genes has typically relied on random integration, a method that is associated with unwanted insertional mutagenesis and positional effects on transgene expression.
OBJECTIVE: To address this barrier, we used genome editing with zinc finger nuclease (ZFN) technology to integrate reporter genes into a safe harbor gene locus (PPP1R12C, also known as AAVS1) in the genome of human embryonic stem cells and human induced pluripotent stem cells for molecular imaging. METHODS AND
RESULTS: We used ZFN technology to integrate a construct containing monomeric red fluorescent protein, firefly luciferase, and herpes simplex virus thymidine kinase reporter genes driven by a constitutive ubiquitin promoter into a safe harbor locus for fluorescence imaging, bioluminescence imaging, and positron emission tomography imaging, respectively. High efficiency of ZFN-mediated targeted integration was achieved in both human embryonic stem cells and induced pluripotent stem cells. ZFN-edited cells maintained both pluripotency and long-term reporter gene expression. Functionally, we successfully tracked the survival of ZFN-edited human embryonic stem cells and their differentiated cardiomyocytes and endothelial cells in murine models, demonstrating the use of ZFN-edited cells for preclinical studies in regenerative medicine.
CONCLUSION: Our study demonstrates a novel application of ZFN technology to the targeted genetic engineering of human pluripotent stem cells and their progeny for molecular imaging in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22967807      PMCID: PMC3518748          DOI: 10.1161/CIRCRESAHA.112.274969

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  46 in total

1.  Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome.

Authors:  Russell C DeKelver; Vivian M Choi; Erica A Moehle; David E Paschon; Dirk Hockemeyer; Sebastiaan H Meijsing; Yasemin Sancak; Xiaoxia Cui; Eveline J Steine; Jeffrey C Miller; Phillip Tam; Victor V Bartsevich; Xiangdong Meng; Igor Rupniewski; Sunita M Gopalan; Helena C Sun; Kathleen J Pitz; Jeremy M Rock; Lei Zhang; Gregory D Davis; Edward J Rebar; Iain M Cheeseman; Keith R Yamamoto; David M Sabatini; Rudolf Jaenisch; Philip D Gregory; Fyodor D Urnov
Journal:  Genome Res       Date:  2010-05-27       Impact factor: 9.043

Review 2.  Genome engineering with zinc-finger nucleases.

Authors:  Dana Carroll
Journal:  Genetics       Date:  2011-08       Impact factor: 4.562

3.  Imaging of embryonic stem cell migration in vivo.

Authors:  Andrew S Lee; Joseph C Wu
Journal:  Methods Mol Biol       Date:  2011

4.  Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells.

Authors:  Zhumur Ghosh; Mei Huang; Shijun Hu; Kitchener D Wilson; Devaveena Dey; Joseph C Wu
Journal:  Cancer Res       Date:  2011-06-06       Impact factor: 12.701

Review 5.  Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.

Authors:  Cheryl Dambrot; Robert Passier; Douwe Atsma; Christine L Mummery
Journal:  Biochem J       Date:  2011-02-15       Impact factor: 3.857

6.  Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting.

Authors:  Jizhong Zou; Colin L Sweeney; Bin-Kuan Chou; Uimook Choi; Jason Pan; Hongmei Wang; Sarah N Dowey; Linzhao Cheng; Harry L Malech
Journal:  Blood       Date:  2011-03-16       Impact factor: 22.113

7.  Synthesis of magnetic resonance-, X-ray- and ultrasound-visible alginate microcapsules for immunoisolation and noninvasive imaging of cellular therapeutics.

Authors:  Brad P Barnett; Aravind Arepally; Matthias Stuber; Dian R Arifin; Dara L Kraitchman; Jeff W M Bulte
Journal:  Nat Protoc       Date:  2011-07-14       Impact factor: 13.491

8.  Modelling the long QT syndrome with induced pluripotent stem cells.

Authors:  Ilanit Itzhaki; Leonid Maizels; Irit Huber; Limor Zwi-Dantsis; Oren Caspi; Aaron Winterstern; Oren Feldman; Amira Gepstein; Gil Arbel; Haim Hammerman; Monther Boulos; Lior Gepstein
Journal:  Nature       Date:  2011-01-16       Impact factor: 49.962

Review 9.  Derivation of human induced pluripotent stem cells for cardiovascular disease modeling.

Authors:  Kamileh Narsinh; Kazim H Narsinh; Joseph C Wu
Journal:  Circ Res       Date:  2011-04-29       Impact factor: 17.367

10.  Genetic engineering of human pluripotent cells using TALE nucleases.

Authors:  Dirk Hockemeyer; Haoyi Wang; Samira Kiani; Christine S Lai; Qing Gao; John P Cassady; Gregory J Cost; Lei Zhang; Yolanda Santiago; Jeffrey C Miller; Bryan Zeitler; Jennifer M Cherone; Xiangdong Meng; Sarah J Hinkley; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2011-07-07       Impact factor: 54.908

View more
  50 in total

1.  Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells.

Authors:  Shijun Hu; Ming-Tao Zhao; Fereshteh Jahanbani; Ning-Yi Shao; Won Hee Lee; Haodong Chen; Michael P Snyder; Joseph C Wu
Journal:  JCI Insight       Date:  2016-06-02

Review 2.  Imaging cardiac stem cell transplantation using radionuclide labeling techniques: clinical applications and future directions.

Authors:  Luka Lezaic; François Haddad; Bojan Vrtovec; Joseph C Wu
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Oct-Dec

Review 3.  Recent developments and clinical studies utilizing engineered zinc finger nuclease technology.

Authors:  Young-Il Jo; Hyongbum Kim; Suresh Ramakrishna
Journal:  Cell Mol Life Sci       Date:  2015-06-19       Impact factor: 9.261

4.  Radiolabeling strategies for radionuclide imaging of stem cells.

Authors:  Esther Wolfs; Catherine M Verfaillie; Koen Van Laere; Christophe M Deroose
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 5.  Tracking gene and cell fate for therapeutic gain.

Authors:  Nigel G Kooreman; Julia D Ransohoff; Joseph C Wu
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

Review 6.  Genome editing in cardiovascular diseases.

Authors:  Alanna Strong; Kiran Musunuru
Journal:  Nat Rev Cardiol       Date:  2016-09-09       Impact factor: 32.419

Review 7.  Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review.

Authors:  Patricia K Nguyen; Evgenios Neofytou; June-Wha Rhee; Joseph C Wu
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

Review 8.  Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.

Authors:  S D Sackett; M E Brown; D M Tremmel; T Ellis; W J Burlingham; J S Odorico
Journal:  Transplant Rev (Orlando)       Date:  2016-02-10       Impact factor: 3.943

9.  Finding Expandable Induced Cardiovascular Progenitor Cells.

Authors:  Ian Y Chen; Joseph C Wu
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 10.  A cut above the rest: targeted genome editing technologies in human pluripotent stem cells.

Authors:  Mo Li; Keiichiro Suzuki; Na Young Kim; Guang-Hui Liu; Juan Carlos Izpisua Belmonte
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.